Abstract:Background: MicroRNA-7 (miR-7) has been observed as a potent tumour suppressor in multiple cancer types including breast cancer. The aim of this study was to investigate the response sensitivities of metastatic breast cancer cells to miR-7 and the roles of miR-7 in the interaction of endothelial cells and metastatic cancer cells.Methods: Expression profile of miRNAs in a breast cancer specimen cohort and breast cancer cells were determined using real-time quantitative miRNA assays. Effect of the altering expression of miR-7 on migration, invasion, proliferation, interaction and underlying molecular mechanism of breast cancer cells and endothelial cells was investigated after treatment with the synthesised mimic of miR-7. Luciferase activity analysis was performed to validate Wave-3 as a novel target of miR-7.Results: miR-7 expression was negatively correlated with the stage, grade and survival of the breast cancer patients. There was also differential expression of miRNAs including miR-7 in the breast cancer cells. The synthesised mimic of miR-7 inhibits the motility and wound healing potential of breast cancer cells. The highly metastatic MDA-MB-231 cells are more sensitive to the miR-7 treatment than the poorly invasive MCF-7 cells. Treatment with miR-7 downregulated the expression of EGFR, IGF1R and Wave3 in MDA-MB-231 cells but not in MCF-7 cells. In addition, we further demonstrated that miR-7 inhibited the proliferation, migration and invasion of endothelial cells. And more importantly, miR-7 suppressed the homing and migration of endothelial cells to more aggressive tumour cell conditions.Conclusions: Given the dual inhibitory effect of miR-7 on metastatic breast cancer cells alone and the interaction of endothelial cells with the tumour-conditioned microenvironment, we suggest miR-7 may be a new therapeutic candidate for its capacity not only to prevent breast cancer cell spreading but also to inhibit tumour-associated angiogenesis in the metastatic breast cancer.

MicroRNA-7: a promising new target in cancer therapy

Molecular Mechanisms and Clinical Applications of Mir-22 in Regulating Malignant Progression in Human Cancer (Review)

Function of microRNA-145 and mechanisms underlying its role in malignant tumor diagnosis and treatment.

Function of Microrna-145 and Mechanisms Underlying Its Role in Malignant Tumor Diagnosis and Treatment

Potential Microrna Targets For Cancer Chemotherapy

miRNA: A Promising Therapeutic Target in Cancer

Tumor-Suppressive and Oncogenic Roles of microRNA-149-5p in Human Cancers

Biological Functions and Molecular Mechanisms of MiR-608 in Cancer

MicroRNAs in Colorectal Cancer As Markers and Targets: Recent Advances.

How MicroRNAs Command the Battle against Cancer

MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer

MicroRNAs (miRNAs): Novel potential therapeutic targets in colorectal cancer

MicroRNAs as potential therapeutic targets for pancreatic cancer

miRNA-based biomarkers, therapies, and resistance in Cancer

MicroRNA-7: A New Intervention Target for Inflammation and Related Diseases

Exploiting the therapeutic potential of microRNAs in human cancer

MicroRNA-7 Inhibits the Growth of Human Non-Small Cell Lung Cancer A549 Cells Through Targeting BCL-2.

MicroRNAs in Cancer Therapeutic Response: Friend and Foe

Microrna-7 Suppresses the Invasive Potential of Breast Cancer Cells and Sensitizes Cells to DNA Damages by Targeting Histone Methyltransferase SET8*

miR-137: a potential therapeutic target for lung cancer

MicroRNA-7 Suppresses the Homing and Migration Potential of Human Endothelial Cells to Highly Metastatic Human Breast Cancer Cells